Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Stem Cells Vol. 24 No. 2 February 2006, pp. 307 -314
doi:10.1634/stemcells.2005-0052; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, X.
Right arrow Articles by Crooks, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X.
Right arrow Articles by Crooks, G. M.

TISSUE-SPECIFIC STEM CELLS

Formation of Pancreatic Duct Epithelium from Bone Marrow During Neonatal Development

Xiuli Wanga, Shundi Gea, Ignacio Gonzalezb, George McNamarac, C. Barth Rountreed, Kenny Kezhe Xia, Grace Huanga, Anil Bhushane, Gay M. Crooksa

a Division of Research Immunology/Bone Marrow Transplantation,
b Department of Pathology,
c Congressman Julian Dixon Cellular Imaging Core,
d Division of Gastroenterology, Hepatology, and Nutrition, and
e Developmental Biology Program, Childrens Hospital Los Angeles, Los Angeles, California, USA

Key Words. Bone marrow transplantation • Epithelial stem cells • Pancreas • Ducts • Neonate • Mice

Correspondence: Gay M. Crooks, M.D., Division of Research Immunology/BMT, Childrens Hospital Los Angeles, 4650 Sunset Blvd., M.S. #62, Los Angeles, CA 90027, USA. Telephone: 323-669-5690; Fax: 323-906-8193; e-mail: gcrooks{at}chla.usc.edu


    ABSTRACT
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Recent reports suggest that bone marrow–derived cells engraft and differentiate into pancreatic tissue at very low frequency after pancreatic injury. All such studies have used adult recipients. The aim of our studies was to investigate the potential of bone marrow to contribute to the exocrine and endocrine components of the pancreas during the normal rapid growth of the organ that occurs during the neonatal period. Five to ten million bone marrow cells from adult, male, transgenic, green fluorescent protein (GFP) mice were injected into neonatal nonobese diabetic/severely compromised immunodeficient/ß2microglobulin-null mice 24 hours after birth. Two months after bone marrow transplantation, pancreas tissue was analyzed with fluorescence immunohistochemistry and fluorescence in situ hybridization (FISH). Co-staining of GFP, with anticytokeratin antibody, and with FISH for the presence of donor Y chromosome indicated that up to 40% of ducts (median 4.6%) contained epithelial cells derived from donor bone marrow. In some of these donor-derived ducts, there were clusters of large and small ducts, all comprised of GFP+ epithelium, suggesting that whole branching structures were derived from donor bone marrow. In addition, rare cells that coexpressed GFP and insulin were found within islets. Unlike pancreatic damage models, no bone marrow–derived vascular endothelial cells were found. In contrast to the neonatal recipients, bone marrow transplanted into adult mice rarely generated ductal epithelium or islet cells (p < .05 difference between adult and neonate transplants). These findings demonstrate the existence in bone marrow of pluripotent stem cells or epithelial precursors that can migrate to the pancreas and differentiate into complex organ-specific structures during the neonatal period.


    INTRODUCTION
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
A debate has raged in recent years over whether stem cells within the bone marrow have the capacity to "transdifferentiate," i.e., to generate nonhematopoietic cell types [13]. Most reports that support this concept have described cells of bone marrow origin present at low frequency in various organs, such as liver [47], lung [8], brain [9, 10], and muscle [1113], after bone marrow or cord blood transplantation. Although the donor cells express tissue-specific markers, the low frequency of such events has created technical difficulties in proving whether true transdifferentiation is being observed rather than contamination of circulating, mature hematopoietic cells. In addition, in almost all studies, some form of tissue injury is present, raising the possibility that trafficking of inflammatory or endothelial precursors (with or without cell fusion) is responsible for at least some of the observations. With these caveats accepted, the obvious possible therapeutic implications necessitate the further careful study of bone marrow as a source of tissue repair and regeneration.

Reports of bone marrow differentiation into pancreatic tissue have been few and contradictory. Some studies have shown rare cells of donor bone marrow origin that coexpress insulin lodged within the pancreatic islets, raising the possibility that bone marrow might be used to regenerate beta cells in the treatment of type 1 diabetes [14, 15]. Other studies have found little if any evidence of beta-cell differentiation [16, 17]. In all previous studies, whether negative or positive, some degree of pancreatic injury was either induced specifically (using the beta-cell toxin streptazotocin) [1517] and/or nonspecifically and subclinically by total body irradiation prior to the bone marrow transplant [1417]. All experiments were performed with adult donors and recipients.

In contrast to previous reports, the current study explored the potential of bone marrow to contribute to the development of the exocrine and endocrine components of the pancreas in the neonatal period during which rapid tissue growth and differentiation occur in the absence of injury. Data presented here show that bone marrow transplanted into immune-deficient neonatal mice contributed to a high percentage of epithelial cells within the pancreas, in some cases forming entire branching ductal structures. Bone marrow transplanted into adult recipients did not generate pancreatic ducts, indicating that factors present specifically during neonatal development are responsible for the recruitment of bone marrow cells with epithelial potential to areas of rapid epithelial growth. These data have important implications for the study of epithelial differentiation in the developing animal and support the existence of significant epithelial potential in the bone marrow that might be harnessed for clinical use.


    MATERIALS AND METHODS
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
5-Bromo-2'-deoxyuridine Analysis of Cell Cycling in Neonatal Mice
To detect the presence of cycling cells in the pancreas, neonatal and adult animals were administered 5-Bromo-2'-deoxyuridine (BrdU) (25 mg/kg; Sigma-Aldrich, St. Louis, http://www.sigmaaldrich.com) by i.p. injection. Pancreas tissue was harvested from animals sacrificed 2 hours after BrdU and processed for fluorescence immunohistochemistry. BrdU was detected with BrdU sheep polyclonal antibody conjugated with Cy3TM, and beta cells and ductal epithelial cells were detected with fluorescein isothiocyanate (FITC)–insulin or FITC–cytokeratin (CK), respectively, by using fluorescence immunohistochemistry staining as below.

Bone Marrow Transplantation into Neonatal Mice
Adult (10- to 12-week-old) male hemizygous mice transgenic for enhanced green fluorescent protein (GFP) gene (C57BL/6-TgN, ACEbEGFP 1Osb/J; The Jackson Laboratory, Bar Harbor, ME, http://www.jax.org) were used as donors for bone marrow transplantation (BMT). Bone marrow cells from femurs and tibia of donors were flushed, washed twice with phosphate-buffered saline (PBS) without Ca and Mg (Mediatech, Inc., Herndon, VA, http://www.cellgro.com), and frozen down in 10% Cryoserv (Edwards Lifesciences, Irvine, CA, http://www.edwards.com) without further manipulation.

Nonobese diabetic/severely compromised immunodeficient/ß2microglobulin-null (Nod/Scid/ß2Mnull) mice were used as recipients of transplanted bone marrow under a protocol approved by the Institutional Animal Care and Use Committee at Childrens Hospital Los Angeles (CHLA). Five to ten million thawed bone marrow cells from GFP+ mice suspended in 50 µl PBS were injected into neonatal mice within 24 hours after birth, through the superficial temporal vein as described [18]. No irradiation or other conditioning regimen was given. Animals were housed in sterile conditions and weaned at 4 weeks of age. Because gender typing of neonatal mice could not be performed at the time of transplant, both male and female recipients were transplanted and analyzed. Recipient mice were sacrificed 2 months post transplantation for analysis. Engraftment of donor-derived cells in peripheral blood was confirmed at the time of sacrifice by identifying GFP+ cells by flow cytometry (FACSCalibur; BD Biosciences–Immunocytometry Systems, San Jose, CA, http://www.bdbiosciences.com/immunocytometry_systems).

In separate experiments, adult Nod/Scid/ß2Mnull mice (8 to 10 weeks old) were transplanted via tail vein injection with 5–10 x 106 adult GFP+ bone marrow cells without irradiation and were sacrificed for analysis 2 months post transplantation.

Histochemistry
After sacrifice, pancreas tissue was dissected and fixed in 10% neutral buffered formalin (Richard-Allan Scientific, Kalamazoo, MI, http://www.rallansci.com) for 6 hours, embedded in paraffin (Leica, Nussloch, Germany, http://www.leica.com), sectioned using a microtome (Leica). Slides of 5-µm thickness were dewaxed with 100% Toluene (Sigma-Aldrich), and rehydrated. Antigen unmasking was performed with Vector unmasking buffer (Vector Laboratories, Inc., Burlingame, CA, http://www.vectorlabs.com) for 12 minutes. Nonspecific binding was blocked with 250–300 µl 100 mM Tris-Buffered Saline (TBS) (pH 7.5) containing 0.1% Tween-20, 3% bovine serum albumin, and 5% normal donkey serum (Immunoglobulin G–free, Protease-free; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, http://www.jacksonimmuno.com) for at least 30 minutes until primary antibody was added. Pancreas tissues from nontransplanted Nod/Scid/ß2Mnull mice and GFP transgenic mice were used as negative and positive controls for GFP staining, respectively.

The following anti-mouse primary antibodies were used for fluorescence immunohistochemistry: BrdU sheep polyclonal antibody conjugated with Cy3TM (Abcam Inc., Cambridge, MA, http://www.abcam.com), platelet/endothelial cell adhesion molecule-1 (PECAM-1) (CD31) goat polyclonal antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, http://www.scbt.com); GFP rabbit polyclonal antibody (Novus Biologicals, Inc., Littleton, CO, http://www.novus-biologicals.com), insulin guinea pig polyclonal antibody (DakoCytomation Inc., Carpinteria, CA, http://www.dakocytomation.com), pan-CK mouse monoclonal antibody (Sigma), and CD45 rat monoclonal antibody (SouthernBiotech, Birmingham, AL, http://www.southernbiotech.com). Secondary antibodies used in the study were anti-goat–FITC, anti-rabbit–Cy3, and anti-mouse–FITC (Jackson ImmunoResearch Laboratories, Inc.). Slides were mounted with Vectashield medium with 4'6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Inc.) after washing three times with TBS containing 0.1% Tween-20 (TBST). Images were viewed with a Leica DMRXA microscope (Bannockburn, IL) using a Plan Apo 20 or 40x/1.25 NA phase 3 DIC or Plan Apo 63x/1.32 oil immersion objective lens. Filter sets used were DAPI, chroma 31000; fluorescein, 41001; and Cy3, 41007a (Chroma Technology Corp., Rockingham, VT, http://www.chroma.com). An LS300W ozone-free xenon arc lamp (Sutter Instrument Co., Novato, CA, http://www.sutter.com) was coupled to the microscope with a liquid light guide. Images were acquired from EasyFISH software with a SkyVision–2/VDS-1300 12-bit digital camera (Applied Spectral Imaging Ltd., Migdal Ha’emek, Israel, http://www.spectral-imaging.com) and printed using Microsoft PowerPoint (Redmond, WA, http://microsoft.com).

Hematoxylin and eosin staining of skin and liver from transplanted and nontransplanted mice and analysis by a blinded pathologist were performed to rule out the presence of graft-versus-host disease (GVHD).

Fluorescence In Situ Hybridization
In cases in which female recipients were used, fluorescence in situ hybridization (FISH) analysis was performed to identify donor Y chromosomes in tissue. For dual staining of CK and mouse Y-paint chromosome, slides were processed with antigen unmasking, as described above, followed by digestion with 0.16% trypsin in diluent (Zymed Laboratories, San Francisco, http://www.zymed.com) for 10 minutes at 37°C and washing with TBST. After blocking, sections were incubated with antibody against mouse CK, followed by incubation with biotinylated anti-mouse antibody, and visualized by fluorescein (dichlorotriazinyl aminofluorescein)– conjugated streptavidin (Jackson ImmunoResearch Laboratories, Inc). Post fixation in 4% paraformaldehyde, slides were sequentially dehydrated in 70%, 90%, and 100% alcohol. One microliter of Y-paint probe (Cy3TM) in 9 µl hybridization buffer (Cambio Ltd., Cambridge, U.K., http://www.cambio.co.uk) was applied on a 22 x 22 mm coverslip. Slides were sealed with rubber cement, denatured in 60°C for 10 minutes, and hybridized overnight at 37°C in humidified container. After washing, the slides were mounted with Vectashield medium containing DAPI. Fluorescein and Cy3 filters were used to reveal CK and Y chromosomes.

Quantification of Donor-Derived Ducts in Recipient Pancreas
Six to 24 sections of pancreas tissue from each mouse were analyzed by fluorescence microscopy. These sections were derived from the 10th, 20th, 30th, 40th, 50th, 60th, and 70th 5-µm sections that spanned the length of the pancreatic tissue, thus providing representative analysis of the entire organ. Ducts were defined in each section based on CK staining of definite duct structures. GFP+ ducts were defined by coexpression of GFP and CK in at least two cells in each clearly defined ductal structure.

Statistical Analysis
Means ± SEM of BrdU+ cells obtained from adult and neonatal mice were determined, and a two-sample t-test was performed. Medians and confidence intervals of GFP+ ducts from recipient animals were given, as these data were nonparametric. Comparison between the neonatal and adult recipients was performed with a Mann-Whitney test. p < .05 was considered significant (two-tailed).


    RESULTS
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Neonatal Pancreas Contains a High Frequency of Cycling Epithelial Ductal and Beta Cells
We hypothesized that the neonatal model may represent a unique scenario in which pancreatic epithelium undergoes rapid cell division without injury, thus providing signals that assist in recruitment of epithelial precursors from the bone marrow. To explore this possibility, BrdU labeling in the pancreas was analyzed 2 hours after administration to otherwise untreated neonatal and adult Nod/Scid/ß2Mnull mice.

Pancreas tissue from neonatal mice displayed irregularly shaped islets and very small ducts compared with their adult counterparts. BrdU+ cells could be seen in both exocrine and endocrine compartments of the pancreas and were significantly more frequent overall in the neonatal than in adult pancreas (37.1 ± 1.9 versus 2.7 ± 0.3 per microscope field, magnification 20x, p < .0001). When ducts and beta cells were specifically analyzed by BrdU staining, a low background level of cell cycling was seen in both cell types from adult mice (6.8% ± 1.4% of ducts and 3.0% ± 1.0% of islets contained at least one BrdU+ cell). The frequency of cycling was significantly higher in the neonatal pancreas in both ductal epithelium (48.1% ± 5.5% of ducts contained BrdU+ cells) and beta cells (26.8% ± 2.2% of islets contained BrdU+ cells) than in the adult pancreas (p < .0001) (Figs. 1A–1DGo). Because epithelial tissue in the neonatal pancreas is rapidly dividing, we reasoned that this scenario may provide a unique stimulus required to recruit epithelial precursors from bone marrow to participate in epithelial growth and differentiation.


Figure 1
View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. Cell cycling of ductal epithelium and beta cells is increased during the neonatal period. BrdU expression (shown as red nuclei) in (A) ductal cells (CK shown as green) and (B) beta cells (insulin shown as green) of pancreas tissue from neonatal (1-day-old) and adult (8-week-old) mice. DAPI (blue) stains all nuclei. Scale bars = 50 µm. The percentage of ducts (C) and islets (D) containing cycling cells (i.e., at least one BrdU+ cell) was significantly increased in neonates compared with adults (*p < .0001 with two-sample t-test). Means and SEM are shown. Abbreviations: BrdU, 5-Bromo-2'-deoxyuridine; CK, cytokera-tin; DAPI, 4'6-diamidino-2-phenylindole.

 
Hematopoietic Engraftment After Bone Marrow Transplantation into Nonirradiated Neonatal Recipients
Hematopoietic engraftment of GFP+ donor bone marrow was determined by analyzing GFP expression in peripheral blood at the time of sacrifice of recipient mice (2 months post transplantation) (Fig. 2AGo). Bone marrow and peripheral blood in donor GFP transgenic mice did not uniformly express the GFP marker (39.0% ± 0.7% of nucleated cells expressed GFP in bone marrow and 88.6% ± 2.1% in peripheral blood) (data not shown). Nontransplanted mice had no background GFP staining in peripheral blood (Fig. 2BGo). Engraftment of donor cells was obtained in all transplanted mice, with 22.3% ± 4.9% GFP+ cells observed in the peripheral blood (n = 9 mice) (Fig. 2CGo). Consistent with the fluorescence-activated cell sorting data, hematopoietic cells of donor origin were also occasionally observed in the blood vessels of recipient pancreas, using fluorescence immunohistochemistry staining (Fig. 2DGo).


Figure 2
View larger version (31K):
[in this window]
[in a new window]
 
Figure 2. Hematopoietic engraftment after neonatal BMT. (A): Whole BM cells from adult male GFP transgenic mice were injected intravenously into newborn Nod/Scid/ß2Mnull mice 24 hours after birth, and recipient mice were sacrificed 2 months post BMT for analysis. Detection of GFP+ donor cells in PB by FACS analysis of (B) nontrans-planted Nod/Scid/ß2Mnull mouse, and (C) Nod/Scid/ß2Mnull mouse transplanted with GFP+ BM. (D): Fluorescence immunohistochemistry staining of pancreas from transplanted animal demonstrating GFP+ blood cells (red) inside vessel stained with PECAM (green). DAPI (blue) stains all nuclei. Scale bars = 50 µm. Abbreviations: BM, bone marrow; BMT, bone marrow transplantation; CK, cytokeratin; DAPI, 4'6-diamidino-2-phenylindole; FACS, fluorescence-activated cell sorting; FISH, fluorescence in situ hybridization; GFP, green fluorescent protein; IHC, immunohistochemistry; Nod/Scid/ß2Mnull, nonobese diabetic/severely compromised immunodeficient/ß2microglobulin-null; PB, peripheral blood; PECAM, platelet/endothelial cell adhesion molecule.

 
Bone Marrow Cells Contribute to Pancreatic Duct Formation When Transplanted into Neonatal Mice
To investigate the capacity of bone marrow cells to contribute to pancreatic tissue during normal neonatal development, GFP+ bone marrow cells were intravenously infused into mice 24 hours after birth without inducing pancreas injury. Pancreas tissues from all animals were analyzed at 2 months post transplantation. Numerous hollow structures lined with uniform, low columnar, tightly spaced cells were partially or completely derived from donor bone marrow cells based on GFP expression. The identity of the structures was determined using the epithelial marker CK and the vascular endothelial marker PE-CAM-1; no cross-reaction between the antibodies was seen, and pancreatic ducts were clearly distinguished from blood vessels in both transplanted and nontransplanted mice (data not shown).

Bone marrow contribution to epithelial ducts was analyzed in a total of 165 pancreas sections from nine mice (in different experiments) sacrificed 2 months after neonatal BMT. Among 4,034 ductal structures identified on the basis of CK staining, a median of 4.6% (range 0.9%–43.1%) of ducts contained cells that coexpressed GFP and CK. Two patterns of ductal engraftment by donor cells could be seen. In the first pattern, ducts were completely or mostly derived from GFP+ donor cells (Figs. 3A, 3BGo). These were recorded as ducts with greater than 50% of epithelial cells coexpressing GFP (Table 1Go). In these cases, clusters of large and small ducts, all expressing GFP, were often found, as if whole branching structures were derived from donor bone marrow. Coexistence of donor- and host-derived ducts in the same section could be seen (Fig. 3BGo), demonstrating the specificity of staining. In the second pattern, only small numbers of epithelial cells of donor origin were found scattered within each of the ducts (Fig. 3CGo). The existence of two or more isolated GFP+ cells per duct with this pattern was recorded as ducts with less than 50% donor cells (Table 1Go). Ducts containing only one GFP+ cell were not recorded. The pattern and specificity of GFP staining in ductal epithelium were validated with pancreas tissues from GFP transgenic mice (Fig. 3DGo) and nontransplanted Nod/Scid/ß2Mnull mice (Fig. 3EGo). In the nine neonatal transplanted mice analyzed at 2 months, a median of 0.2% (range 0%–31.3%) of all ducts had more than 50% donor cells and 4.1% (range 0.9%–11.8%) of all ducts had less than 50% donor cells (Table 1Go). The colocalization of CK and GFP in the donor-derived ductal epithelial cells can be clearly shown at higher magnification (Figs. 4A–4CGo).


Figure 3
View larger version (113K):
[in this window]
[in a new window]
 
Figure 3. Formation of pancreatic ducts derived from GFP+ donor bone marrow. Fluorescence immunohistochemistry of pancreas tissue from transplanted animals with CK (green), GFP (red) antibodies, and DAPI (blue) (A–C). Different patterns of donor engraftment are shown. (A): Clusters of ducts, all of which contain 100% of epithelium of donor origin. (B): Ducts derived completely from donor cells are seen adjacent to recipient-derived ducts. (C): Less than 50% of cells lining duct are of donor origin. (D): Pancreatic ducts from GFP transgenic donor (positive control). (E): Pancreatic ducts from nontransplanted animal (negative control) show CK expression (green) but not GFP. Scale bars = 50 µm. Abbreviations: CK, cytokeratin; DAPI, 4'6-diamidino-2-phenylindole; GFP, green fluorescent protein.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Frequency of donor-derived pancreatic ducts after neonatal BMT

 

Figure 4
View larger version (32K):
[in this window]
[in a new window]
 
Figure 4. Colocalization of CK and GFP in donor-derived duct epithelial cells. Fluorescence immunohistochemistry staining of pancreas section from transplanted animal with CK (green) and GFP (red) antibodies and DAPI (blue). Frames (A, B) show CK (green) and GFP (red) coexpression in pancreatic duct, respectively. (C): Merged image of (A, B). Scale bars = 50 µm. Abbreviations: CK, cytokeratin; DAPI, 4'6-diamidino-2-phenylindole; GFP, green fluorescent protein.

 
FISH and CK fluorescence immunohistochemistry analysis of the sections from female recipients showed donor-derived ductal epithelial cells with Y chromosome, confirming the presence of male donor cells contributing to the epithelial lining of the pancreatic ducts (Fig. 5Go). Analysis of serial sections taken along the length of the pancreas showed that the bone marrow–derived ducts tended to be found toward the center of the organ. These clusters of predominantly GFP+ ducts represented interlobular ducts (large ducts typically surrounded by loose mesenchymal tissue); in contrast, the small intralobular ducts surrounded by acinar tissue rarely contained GFP+ epithelial cells. In some areas, approximately 50% of the interlobular ducts were GFP+.


Figure 5
View larger version (83K):
[in this window]
[in a new window]
 
Figure 5. Coexpression of CK and Y chromosome in donor-derived duct epithelial cells. Dual staining of CK (green) and Y chromosome (red) in the four different pancreas sections from transplanted animals showing coexpression of CK and Y chromosome in the donor-derived duct epithelial cells (A) (arrows). Pancreas sections from male animal as positive (B) and female animal as negative (C) controls for fluorescence in situ hybridization staining. Scale bars = 25 µm. Abbreviations: CK, cytokeratin; DAPI, 4'6-diamidino-2-phenylindole.

 
To rule out the presence of contaminating hematopoietic cells, CD45 staining was applied to the sections from transplanted and nontransplanted mouse pancreas. No duct epithelial cells coexpressed CD45 (data not shown).

Of note, no GFP-expressing cells were found in 1,300 blood vessels (identified by expression of PECAM-1) in any of the nine animals transplanted during the neonatal period. Thus, bone marrow cells did not contribute to the formation of pancreatic blood vessels in the neonatal bone marrow transplant model.

Bone Marrow–Derived Cells Occurred at Low Frequency in Islets
Co-staining of pancreatic tissue sections showed occasional bone marrow–derived cells within the islets that expressed both GFP and insulin (data not shown). Among a total 438 islets identified in pancreas sections from five mice analyzed 2 months after BMT, 2.5% of islets appeared to contain one or more donor-derived cells coexpressing GFP and insulin. However, only rare cells (1.3%) within each positive islet expressed GFP (Table 2Go). To further confirm the donor origin of these GFP+insulin+ cells, pancreas sections stained with GFP/insulin were processed for FISH staining and found to have single X and Y chromosome FISH signals, demonstrating diploidy (data not shown).


View this table:
[in this window]
[in a new window]
 
Table 2. Frequency of donor-derived GFP+insulin+ cells after neonatal BMT

 
Ductal Generation from Bone Marrow Is Rare After Transplantation Performed in Adult Recipients
To test whether a similar pattern of ductal engraftment from bone marrow could be seen when transplantation occurred outside the neonatal period, GFP+ bone marrow cells were infused into nonirradiated adult Nod/Scid/ß2Mnull mice. High levels of hematopoietic engraftment were seen at the time of sacrifice (33.9% ± 5.8% GFP+ cells in peripheral blood). Among 2,352 ductal structures from four mice sacrificed after 2 months, a median of 0.5% (range 0%–1.6%) of ducts contained GFP+ cells, 0.1% (range 0%–0.2%) of ducts contained more than 50% donor GFP+ epithelial cells, and 0.4% (range 0%–1.4%) of ducts contained less than 50% donor GFP+ epithelial cells (Table 1Go). Analysis of the data from all animals studied confirmed that the number of ducts containing donor-derived cells was significantly higher in neonatal than adult recipients (p < .05). No beta cells of donor bone marrow origin were found in animals transplanted as adults.


    DISCUSSION
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The diverse array of the body’s epithelial cells is developed and maintained by mechanisms that are largely unknown [19]. Although many organs are believed to contain epithelial stem cells responsible for the regeneration of mature specialized epithelial cells during adult life, the identification and source of these stem cells are controversial [20]. Findings presented here demonstrate the existence of cells within the marrow with the capacity to migrate to the neonatal pancreas and differentiate at high frequency into complex epithelial structures.

Previous reports have suggested a role for bone marrow in epithelial differentiation in multiple organs [21]. In these studies, however, the rarity of the phenomenon, usually demonstrated as single donor cells lodged randomly within a background of recipient tissue, has made interpretation difficult. The possibility of fusion between donor hematopoietic cells and host tissue has been raised to explain the data [22]. To our knowledge, in all such reports, BMT was performed during adult life. In the case of bone marrow–to–pancreas differentiation, reports have shown either no donor contribution to pancreatic tissue [16, 17] or rare events of engraftment/differentiation from individual bone marrow– derived cells in islets [14] and/or endothelium [15, 23]. The current report is distinguished from all others by the predominance of ductal differentiation from bone marrow infused during the neonatal period. As with previous reports, we found an almost complete absence of donor engraftment in the pancreatic ducts of mice transplanted during adult life, suggesting that the neonatal period offers a unique setting for this process. It has been extensively reported that bone marrow cells are able to differentiate into cells of other organs, including the pancreas. However, all such studies used models with various tissue damage. To investigate the differentiation potential of bone marrow cells under physiological conditions, irradiation and specific pancreatic damage were eliminated from our study. Although the C57BL/6-TgN to Nod/Scid/ß2Mnull combination is not a syngeneic transplant model, GVHD-mediated tissue damage did not occur clinically or at the histologic level, suggesting that this represents a genuine nondamage setting.

As noted in some previous reports using adult models, we also found rare cells within the islets of neonatal recipients. FISH analysis confirmed that the cells were of donor origin, suggesting that bone marrow cells may also have the potential for differentiation into the endocrine components of the pancreas. The question of whether adult stem cells capable of beta-cell neogenesis exist in the pancreas is a controversial one. Insulin-producing cells can be seen integrated into the lining of ducts [24], and many investigators have concluded that pancreatic stem cells exist in and around the ducts [2527]. Interestingly, Polak et al. reported that during human fetal development, endocrine differentiation is associated with the central, rather than peripheral, ducts [28]. The loose surrounding mesenchyme of these central ducts is similar to that of the interlobular ducts noted in our study to be the predominant epithelium generated from bone marrow.

However, recent papers concluded that all beta-cell production during adult life is generated by self-replication rather than from adult stem cells [29, 30]. Without a method for lineage tracing, it is difficult to say whether the isolated beta cells of bone marrow origin we observed were derived from interlobular ductal cells. However, the chimerism created within the pancreatic ducts using the neonatal bone marrow transplant model provides a potential experimental tool to track the lineage fate of ductal cells in the adult animal.

The complete absence of bone marrow differentiation into vascular endothelium seen in this study may be because of the lack of tissue injury used in our neonatal transplant model [23]. Even in those reports that did not induce pancreas-specific injury (e.g., from streptozotocin or pancreatectomy), total body irradiation was used to obtain a hematopoietic graft [1417]. Irradiation, even at sublethal doses, is known to induce widespread subclinical organ toxicity [31] and thus could result in recruitment of inflammatory cells and/or endothelial precursors to injured pancreas tissue [32, 33].

The findings here neither support nor reject the possibility of "transdifferentiation" from hematopoietic stem cells as the mechanism for epithelial development from bone marrow. However, the fact that the data were achieved using unfractionated "whole" bone marrow makes it equally likely that a nonhematopoietic epithelial progenitor/precursor is responsible for the generation of ducts in this model. In support of this, in a previous report, the CD45 fraction of splenic cells was able to generate pancreatic ductal epithelial cells when transplanted into diabetic NOD mice [34]. In the current study, the development of clusters of whole branching ductal structures of marrow origin suggests that the bone marrow cells responsible have considerable proliferative and even clonogenic capacity although the possibility of cell fusion cannot be completely ruled out as an explanation for the findings.

The success of the neonatal model in revealing the epithelial potential of bone marrow suggests that factors regulating proliferation, differentiation, and/or homing of these precursors are unique to (or at least significantly more active in) the neonatal period than in the adult. A very recent study demonstrated that factors present in young serum restored the proliferation and regeneration capacity of stem or progenitor cells in aged animals, suggesting that the behavior of adult stem cells can be altered by exposure to a young systemic environment [35]. Extensive expansion of the rat beta-cell mass during the early neonatal period has been described and is produced at least in part by a high frequency of beta cells in cell cycle during the first 2 days after birth [36]. During embryonic development, soluble factors produced in the mesenchyme, such as Fibroblast Growth Factor 10 (FGF10) and follistatin, are key to the regulation of growth and differentiation of the exocrine and endocrine pancreas [3739]. However, little information is available on the regulation of ductal growth and differentiation during the neonatal period. One recent study reported that rapidly proliferating cells that express c-kit are found lining the embryonic and neonatal pancreatic ducts, but that proliferation falls rapidly during the first week of postnatal life [40]. c-kit is also expressed on hematopoietic stem cells, and its ligand acts to stimulate proliferation and prevent apoptosis in hematopoietic stem cells [41], providing another potential link between the hematopoietic and pancreatic organs.

In summary, the neonatal transplant model demonstrates the existence in bone marrow of epithelial precursors that can migrate to the pancreas and differentiate into complex, organ-specific ductal structures. Identifying the unique factors at play in pancreatic development during neonatal life may allow us to harness the process of epithelial engraftment and differentiation after BMT in adult recipients.


    ACKNOWLEDGMENTS
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We thank the animal facility of CHLA and Denise Carbonaro for assistance with animal care and transplantation, and Dr. Donald Kohn for his helpful discussions. Fluorescence microscopy was performed in the Congressman Julian Dixon Cellular Imaging Core of the Saban Research Institute, CHLA. This work was generously supported by grants from the Seaver Institute and NIH (R01-DK68719).

DISCLOSURES
The authors indicate no potential conflicts of interest.


    REFERENCES
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. DeWitt N, Knight J. Biologists question adult stem-cell versatility. Nature 2002;416:354.[Medline]

  2. Holden C, Vogel G. Plasticity: Time for a reappraisal? Science 2002; 296:2126–2129.[Abstract/Free Full Text]

  3. Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood 2003;102:3483–3493.[Abstract/Free Full Text]

  4. Petersen BE, Bowen WC, Patrene KD et al. Bone marrow as a potential source of hepatic oval cells. Science 1999;284:1168–1170.[Abstract/Free Full Text]

  5. Theise ND, Badve S, Saxena R et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000;31:235–240.[CrossRef][Medline]

  6. Wang X, Ge S, McNamara G et al. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood 2003; 101:4201–4208.[Abstract/Free Full Text]

  7. Newsome PN, Johannessen I, Boyle S et al. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology 2003;124:1891–1900.[CrossRef][Medline]

  8. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105: 369–377.[CrossRef][Medline]

  9. Brazelton TR, Rossi FM, Keshet GI et al. From marrow to brain: Expression of neuronal phenotypes in adult mice. Science 2000;290: 1775–1779.[Abstract/Free Full Text]

  10. Mezey E, Chandross KJ, Harta G et al. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000;290:1779–1782.[Abstract/Free Full Text]

  11. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701–705.[CrossRef][Medline]

  12. Ferrari G, Cusella-De Angelis G, Coletta M et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528–1530.[Abstract/Free Full Text]

  13. Goodell MA, Jackson KA, Majka SM et al. Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci 2001;938:208–220.[Abstract/Free Full Text]

  14. Ianus A, Holz GG, Theise ND et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003;111:799–801.[CrossRef][Medline]

  15. Hess D, Li L, Martin M et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003;21:755–756.[CrossRef][Medline]

  16. Choi JB, Uchino H, Azuma K et al. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 2003;46:1366–1374.[CrossRef][Medline]

  17. Lechner A, Yang YG, Blacken RA et al. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 2004;53:616–623.[CrossRef][Medline]

  18. Sands MS, Barker JE. Percutaneous intravenous injection in neonatal mice. Lab Anim Sci 1999;49:328–330.[Medline]

  19. Slack JM. Stem cells in epithelial tissues. Science 2000;287:1431–1433.[Abstract/Free Full Text]

  20. Potten CS, Loeffler M. Stem cells: Attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990;110: 1001–1020.[Abstract/Free Full Text]

  21. Grove JE, Bruscia E, Krause DS. Plasticity of bone marrow-derived stem cells. STEM CELLS 2004;22:487–500.[Abstract/Free Full Text]

  22. Wang X, Willenbring H, Akkari Y et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003;422:897–901.[CrossRef][Medline]

  23. Mathews V, Hanson PT, Ford E et al. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 2004;53:91–98.[CrossRef][Medline]

  24. Oertel JE, Heffess CS, Oertel YC. Pancreas. In: Sternberg SS, ed. Histology for Pathologists. 2nd ed. New York, NY: Raven Press; 652–668, 1992.

  25. Gu D, Lee MS, Krahl T et al. Transitional cells in the regenerating pancreas. Development 1994;120:1873–1881.[Abstract]

  26. Bonner-Weir S. Islet growth and development in the adult. J Mol Endocrinol 2000;24:297–302.[CrossRef][Medline]

  27. Lechner A, Habener JF. Stem/progenitor cells derived from adult tissues: Potential for the treatment of diabetes mellitus. Am J Physiol Endocrinol Metab 284 E259–E266, 2003.[Abstract/Free Full Text]

  28. Polak M, Bouchareb-Banaei L, Scharfmann R et al. Early pattern of differentiation in the human pancreas. Diabetes 2000;49:225–232.[Medline]

  29. Dor Y, Brown J, Martinez OI et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004;429:41–46.[CrossRef][Medline]

  30. Georgia S, Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 2004;114:963–968.[CrossRef][Medline]

  31. Chapel A, Bertho JM, Bensidhoum M et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 2003;5: 1028–1038.[CrossRef][Medline]

  32. Pieroni PL, Rudick J, Adler M et al. Effect of irradiation on the canine exocrine pancreas. Ann Surg 1976;184:610–614.[Medline]

  33. Day DL, Carpenter BL. Abdominal complications in pediatric bone marrow transplant recipients. Radiographics 1993;13:1101–1112.[Abstract/Free Full Text]

  34. Kodama S, Kuhtreiber W, Fujimura S et al. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003;302:1223–1227.[Abstract/Free Full Text]

  35. Conboy IM, Conboy MJ, Wagers AJ et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005;433:760–764.[CrossRef][Medline]

  36. Scaglia L, Cahill CJ, Finegood DT et al. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 1997;138:1736–1741.[Abstract/Free Full Text]

  37. Golosow N, Grobstein C. Epitheliomesenchymal interaction in pancreatic morphogenesis. Dev Biol 1962;4:242–255.[CrossRef][Medline]

  38. Miralles F, Czernichow P, Scharfmann R. Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development. Development 1998;125:1017–1024.[Abstract]

  39. Bhushan A, Itoh N, Kato S et al. Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 2001;128:5109–5117.[Medline]

  40. Yashpal NK, Li J, Wang R. Characterization of c-Kit and nestin expression during islet cell development in the prenatal and postnatal rat pancreas. Dev Dyn 2004;229:813–825.[CrossRef][Medline]

  41. Lyman SD, Jacobsen SE. c-kit ligand and Flt3 ligand: Stem/progenitor cell factors with overlapping yet distinct activities. Blood 1998;91:1101–1134.[Free Full Text]

Received February 4, 2005; accepted for publication July 25, 2005.



This article has been cited by other articles:


Home page
GutHome page
F Marrache, S Pendyala, G Bhagat, K S Betz, Z Song, and T C Wang
Role of bone marrow-derived cells in experimental chronic pancreatitis
Gut, August 1, 2008; 57(8): 1113 - 1120.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C. B. Rountree, L. Barsky, S. Ge, J. Zhu, S. Senadheera, and G. M. Crooks
A CD133-Expressing Murine Liver Oval Cell Population with Bilineage Potential
Stem Cells, October 1, 2007; 25(10): 2419 - 2429.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. E. Butler, A. Huang, P. N. Rao, A. Bhushan, W. J. Hogan, R. A. Rizza, and P. C. Butler
Hematopoietic Stem Cells Derived From Adult Donors Are Not a Source of Pancreatic {beta}-Cells in Adult Nondiabetic Humans
Diabetes, July 1, 2007; 56(7): 1810 - 1816.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. M. Bruscia, E. C. Ziegler, J. E. Price, S. Weiner, M. E. Egan, and D. S. Krause
Engraftment of Donor-Derived Epithelial Cells in Multiple Organs Following Bone Marrow Transplantation into Newborn Mice
Stem Cells, October 1, 2006; 24(10): 2299 - 2308.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
S. Ge, G. M. Crooks, G. McNamara, and X. Wang
Fluorescent Immunohistochemistry and In Situ Hybridization Analysis of Mouse Pancreas Using Low-power Antigen-retrieval Technique
J. Histochem. Cytochem., July 1, 2006; 54(7): 843 - 847.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, X.
Right arrow Articles by Crooks, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X.
Right arrow Articles by Crooks, G. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/